Requip Xl Uzatilmis Salimli Tablet 2 Mg

Description

Requip XL Uzatılmış Salımlı Tablet 2 mg is a pharmaceutical formulation containing the active ingredient ropinirole hydrochloride at a dose of 2 mg. It is an extended-release tablet primarily used in the management of neurological conditions such as Parkinson’s disease and Restless Legs Syndrome (RLS). The medication belongs to the class of dopamine agonists, which mimic the action of dopamine, a critical neurotransmitter involved in controlling movement and muscle function.

Pharmacological Action

Ropinirole acts by stimulating dopamine receptors in the brain, compensating for the reduced dopamine levels characteristic of Parkinson’s disease and alleviating symptoms of RLS. By activating these receptors, ropinirole helps improve motor control, reduce tremors, stiffness, and muscle rigidity, and relieve uncomfortable sensations in the legs that prompt movement in RLS patients.

Indications and Usage

Requip XL is indicated for:

• Parkinson’s Disease: Used either as monotherapy in early stages to delay levodopa introduction or in combination with levodopa during advanced stages to manage motor fluctuations.

• Restless Legs Syndrome: Though the immediate-release form is more commonly prescribed, ropinirole addresses the urge to move the legs and associated discomfort.

Dosage and Administration

• The starting dose for Requip XL is typically 2 mg once daily.

• Dose increments of 2 mg may be made weekly or at longer intervals based on clinical response and tolerability.

• The tablets should be swallowed whole, not chewed or crushed, to maintain the extended-release properties.

• It is recommended to take the medication at the same time each day to maintain steady blood levels.

Storage

Requip XL should be stored at room temperature, ideally between 20°C to 25°C (68°F to 77°F), protected from moisture and light.

Side Effects and Precautions

Common Side Effects

• Nausea and vomiting

• Dizziness and lightheadedness

• Fatigue and drowsiness

• Upset stomach

• Headache

Serious Side Effects

• Sudden sleep episodes

• Hallucinations or confusion

• Fainting or severe dizziness

• Involuntary movements (dyskinesia)

Patients should report any severe or unusual symptoms to their healthcare provider promptly.

Contraindications and Warnings

• Hypersensitivity to ropinirole or any tablet components

• Severe kidney or liver impairment

• Caution in patients with cardiac conditions

• Not recommended for use in individuals under 18 years of age

• Use during pregnancy and breastfeeding only if clearly needed and prescribed by a doctor

Composition and Formulation

Requip XL tablets contain ropinirole hydrochloride in a prolonged-release matrix designed to release the medication slowly over time. The 2 mg tablet is pink, capsule-shaped, film-coated, and marked with specific identifiers for dosage verification.

Summary Table of Requip XL 2 mg

Conclusion

Requip XL Uzatılmış Salımlı Tablet 2 mg is a clinically valuable medication for managing Parkinson’s disease and Restless Legs Syndrome by compensating for dopamine deficiency in the brain. Its extended-release formulation allows for once-daily dosing, improving patient compliance. However, careful monitoring for side effects and adherence to prescribed dosing schedules is essential for safe and effective treatment.

This article is based on detailed drug information from authoritative sources including MedlinePlus, WebMD, Mayo Clinic, and Medicines.org.uk, ensuring a comprehensive and accurate overview of Requip XL and its clinical use.